{"entity":{"id":"nct06702618","kind":"trial","name":"Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer","aka":[],"tldr":"A phase 2 trial of Fulvestrant and TQB3616 in advanced solid tumours, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., active and no longer recruiting.","summary":"Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer is a phase 2 interventional study registered as NCT06702618 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., with 33 participants enrolled, started 2025-02-20 and due to reach its primary completion in 2026-06. Interventions recorded: TQB3616 capsule+Fulvestrant Injection.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06702618","url":"https://clinicaltrials.gov/study/NCT06702618"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["fulvestrant","tqb3616"],"companies":["sino-biopharm"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06702618","phase":"2","setting":"Evaluation of the Efficacy and Safety of TQB3616 Capsules Combined With Hormonal Therapy in a Phase II Clinical Trial for Cyclin-dependent Kinases 4 and 6（CDK4/6)Inhibitor-Resistant, Hormone Receptor(HR)-Positive, Human Epidermal Growth Factor Receptor 2(HER2)-Negative Recurrent/Metastatic Breast Cancer","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","enrolled":33,"outcomes":[]},"route":"/trials/nct06702618/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"fulvestrant","kind":"drug","name":"Fulvestrant","route":"/drugs/fulvestrant/"},{"id":"tqb3616","kind":"drug","name":"TQB3616","route":"/drugs/tqb3616/"}],"company":[{"id":"sino-biopharm","kind":"company","name":"Sino Biopharmaceutical (Chia Tai Tianqing)","route":"/companies/sino-biopharm/"}]}}